MFG
NUVB icon

Merit Financial Group’s Nuvation Bio NUVB Stock Holding History

Merit Financial Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99K Buy
17,431
+2,203
+14% +$10.8K ﹤0.01% 2221
2026
Q1 		$65.3K Buy
15,228
+142
+0.9% +$791 ﹤0.01% 2047
2025
Q4 		$135K Buy
15,086
+259
+2% +$1.6K ﹤0.01% 1865
2025
Q3 		$54.9K Buy
+14,827
New +$40.4K ﹤0.01% 1770

Other funds holding NUVB

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $310M AUM 23.22% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Merit Financial Group's NUVB Position: Q2 2026 in Review

Merit Financial Group increased its Nuvation Bio (NUVB) stake by 14% in Q2 2026, buying an estimated $10.8K and bringing the position to 17,431 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Merit Financial Group first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. The position peaked at $135K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Merit Financial Group held 17,431 shares of Nuvation Bio worth $99K as of Q2 2026.
  • Merit Financial Group bought 2,203 Nuvation Bio shares in Q2 2026, an estimated $10.8K.
  • Nuvation Bio made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2221 holding.
  • Merit Financial Group first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • Merit Financial Group's Nuvation Bio position peaked at $135K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.